세계의 C 반응성 단백질(CRP) 검사 시장 보고서 : 동향, 예측 및 경쟁 분석(-2030년)

C-Reactive Protein Testing Trends and Forecast

The future of the global C-reactive protein testing market looks promising with opportunities in the clinic, hospital, laboratories, assisted living healthcare facilities, and home markets. The global C-reactive protein testing market is expected to reach an estimated $6.1 billion by 2030 with a CAGR of 2.8% from 2024 to 2030. The major drivers for this market are rising frequency of cardiovascular disorders, expanding government programs to introduce point-of-care screening and create cutting-edge methods for C-reactive protein (CRP) testing, as well as, increasing rates of chronic illnesses such cardiovascular disease, rheumatoid arthritis, and inflammatory disorders.

A more than 150-page report is developed to help in your business decisions.

C-Reactive Protein Testing by Segment

The study includes a forecast for the global C-reactive protein testing by assay type, detection range, disease, end use, and region.

C-Reactive Protein Testing Market by Assay Type [Shipment Analysis by Value from 2018 to 2030]:

• Immunoturbidimetric Assay
• ELISA
• Chemiluminescence Immunoassay
• Others

C-Reactive Protein Testing Market by Detection Range [Shipment Analysis by Value from 2018 to 2030]:

• hs-CRP
• Conventional CRP
• cCRP

C-Reactive Protein Testing Market by Disease [Shipment Analysis by Value from 2018 to 2030]:

• Cardiovascular Diseases
• Cancer
• Rheumatoid Arthritis
• Inflammatory Bowel Disease
• Endometriosis
• Lupus
• Others

C-Reactive Protein Testing Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Clinics
• Hospitals
• Laboratories
• Assisted Living Healthcare Facilities
• Home
• Others

C-Reactive Protein Testing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of C-Reactive Protein Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies C-reactive protein testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the C-reactive protein testing companies profiled in this report include-

• Thermo Fisher Scientific
• F. Hoffmann-La Roche
• Danaher
• Quest Diagnostics
• Siemens Healthineers
• Abbott
• Merck
• Zoetis
• Ortho Clinical Diagnostics
• Getein Biotech

C-Reactive Protein Testing Market Insights

Lucintel forecasts that cardiovascular diseases will remain the largest segment over the forecast period due to the rise in the frequency of cardiovascular disorders.

North America will remain the largest region over the forecast period due to rising cardiovascular disease incidence, a regular stream of product introductions, and the existence of established industry competitors.

Features of the Global C-Reactive Protein Testing Market

Market Size Estimates: C-reactive protein testing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: C-reactive protein testing market size by various segments, such as by assay type, detection range, disease, end use, and region in terms of value ($B).

Regional Analysis: C-reactive protein testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different assay type, detection range, disease, end use, and regions for the C-reactive protein testing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the C-reactive protein testing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the C-reactive protein testing market size?

Answer: The global C-reactive protein testing market is expected to reach an estimated $6.1 billion by 2030.

Q2. What is the growth forecast for C-reactive protein testing market?

Answer: The global C-reactive protein testing market is expected to grow with a CAGR of 2.8% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the C-reactive protein testing market?

Answer: The major drivers for this market are rising frequency of cardiovascular disorders, expanding government programs to introduce point-of-care screening and create cutting-edge methods for C-reactive protein (CRP) testing, as well as, increasing rates of chronic illnesses such cardiovascular disease, rheumatoid arthritis, and inflammatory disorders.

Q4. What are the major segments for C-reactive protein testing market?

Answer: The future of the global C-reactive protein testing market looks promising with opportunities in the clinic, hospital, laboratories, assisted living healthcare facilities, and home markets.

Q5. Who are the key C-reactive protein testing market companies?

Answer: Some of the key C-reactive protein testing companies are as follows.

• Thermo Fisher Scientific
• F. Hoffmann-La Roche
• Danaher
• Quest Diagnostics
• Siemens Healthineers
• Abbott
• Merck
• Zoetis
• Ortho Clinical Diagnostics
• Getein Biotech

Q6. Which C-reactive protein testing market segment will be the largest in future?

Answer: Lucintel forecasts that cardiovascular diseases will remain the largest segment over the forecast period due to the rise in the frequency of cardiovascular disorders.

Q7. In C-reactive protein testing market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to rising cardiovascular disease incidence, a regular stream of product introductions, and the existence of established industry competitors.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the C-reactive protein testing market by assay type (immunoturbidimetric assay, elisa, chemiluminescence immunoassay, and others), detection range (hs-CRP, conventional CRP, and cCRP), disease (cardiovascular diseases, cancer, rheumatoid arthritis, inflammatory bowel disease, endometriosis, lupus, and others), end use (clinics, hospitals, laboratories, assisted living healthcare facilities, home, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global C-Reactive Protein Testing Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global C-Reactive Protein Testing Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global C-Reactive Protein Testing Market by Assay Type
  • 3.3.1: Immunoturbidimetric Assay
  • 3.3.2: ELISA
  • 3.3.3: Chemiluminescence Immunoassay
  • 3.3.4: Others
• 3.4: Global C-Reactive Protein Testing Market by Detection Range
  • 3.4.1: hs-CRP
  • 3.4.2: Conventional CRP
  • 3.4.3: cCRP
• 3.5: Global C-Reactive Protein Testing Market by Disease
  • 3.5.1: Cardiovascular Diseases
  • 3.5.2: Cancer
  • 3.5.3: Rheumatoid Arthritis
  • 3.5.4: Inflammatory Bowel Disease
  • 3.5.5: Endometriosis
  • 3.5.6: Lupus
  • 3.5.7: Others
• 3.6: Global C-Reactive Protein Testing Market by End Use
  • 3.6.1: Clinics
  • 3.6.2: Hospitals
  • 3.6.3: Laboratories
  • 3.6.4: Assisted Living Healthcare Facilities
  • 3.6.5: Home
  • 3.6.6: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global C-Reactive Protein Testing Market by Region
• 4.2: North American C-Reactive Protein Testing Market
  • 4.2.1: North American C-Reactive Protein Testing Market by Disease: Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus, and Others
  • 4.2.2: North American C-Reactive Protein Testing Market by End Use: Clinics, Hospitals, Laboratories, Assisted Living Healthcare Facilities, Home, and Others
• 4.3: European C-Reactive Protein Testing Market
  • 4.3.1: European C-Reactive Protein Testing Market by Disease: Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus, and Others
  • 4.3.2: European C-Reactive Protein Testing Market by End Use: Clinics, Hospitals, Laboratories, Assisted Living Healthcare Facilities, Home, and Others
• 4.4: APAC C-Reactive Protein Testing Market
  • 4.4.1: APAC C-Reactive Protein Testing Market by Disease: Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus, and Others
  • 4.4.2: APAC C-Reactive Protein Testing Market by End Use: Clinics, Hospitals, Laboratories, Assisted Living Healthcare Facilities, Home, and Others
• 4.5: ROW C-Reactive Protein Testing Market
  • 4.5.1: ROW C-Reactive Protein Testing Market by Disease: Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus, and Others
  • 4.5.2: ROW C-Reactive Protein Testing Market by End Use: Clinics, Hospitals, Laboratories, Assisted Living Healthcare Facilities, Home, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global C-Reactive Protein Testing Market by Assay Type
  • 6.1.2: Growth Opportunities for the Global C-Reactive Protein Testing Market by Detection Range
  • 6.1.3: Growth Opportunities for the Global C-Reactive Protein Testing Market by Disease
  • 6.1.4: Growth Opportunities for the Global C-Reactive Protein Testing Market by End Use
  • 6.1.5: Growth Opportunities for the Global C-Reactive Protein Testing Market by Region
• 6.2: Emerging Trends in the Global C-Reactive Protein Testing Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global C-Reactive Protein Testing Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global C-Reactive Protein Testing Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Thermo Fisher Scientific
• 7.2: F. Hoffmann-La Roche
• 7.3: Danaher
• 7.4: Quest Diagnostics
• 7.5: Siemens Healthineers
• 7.6: Abbott
• 7.7: Merck
• 7.8: Zoetis
• 7.9: Ortho Clinical Diagnostics
• 7.10: Getein Biotech